Table 2.
The tumor phage recovery, and number of phage clones and the soluble scFvs, derived from the higher tumor-binding phage clones, evaluated for tumor binding and the number that demonstrated tumor binding
| Patient ID | Tumor phage recovery (% of dose) | Phage clones | Soluble scFv | ||
|---|---|---|---|---|---|
| Number evaluated | Number binding to tumor (%) | Number evaluated | Number binding to tumor (%) | ||
| 180-12 | 1.2 × 10−3 | 40 | 11 (28) | 0 | 0 |
| 180-13 | 3.1 × 10−3 | 469 | 99 (21) | 58 | 32 (55) |
| 180-14 | 4.1 × 10−4 | 241 | 50 (21) | 9 | 4 (44) |
| 180-15 | 2.9 × 10−4 | 288 | 40 (14) | 11 | 9 (82) |
| 180-16 | 1.7 × 10−3 | 176 | 4 (2) | 0 | 0 |
| 180-17 | 7.6 × 10−4 | 24 | 0 | 0 | 0 |